Burosumab for treating FGF23-related hypophosphataemia in tumour-induced osteomalacia [ID3924 ]

  • In development
  • GID-TA10822
  • Expected publication date: TBC

Documents

Documents created during the development process.

Topic selection

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators